GLOBAL
EVENTS & PRESENTATIONS
Upcoming Events
2020 RNAi Roundtable: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type I
Past Events
2020 RNAi Roundtable: Early Stage RNAi Therapeutics Pipeline
Bank of America Securities 2020 Napa Biopharma Conference
2020 RNAi Roundtable: ALN-AGT, in Development for the Treatment of Hypertension
Goldman Sachs 41st Annual Global Healthcare Conference
Alnylam Pharmaceuticals Conference Call to Discuss Full Results from the ILLUMINATE-A Phase 3 Study of Lumasiran
Looking for specific information that isn't listed above?
Contact: investors@alnylam.com